Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients S Dahlhaus, R Hoepner, A Chan, I Kleiter, O Adams, C Lukas, K Hellwig, ... J Neurol Neurosurg Psychiatry 84 (10), 1068-1074, 2013 | 118 | 2013 |
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab‐associated progressive multifocal leukoencephalopathy C Warnke, G Geldern, P Markwerth, T Dehmel, R Hoepner, R Gold, ... Annals of neurology 76 (6), 792-801, 2014 | 101 | 2014 |
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations I Ayzenberg, R Hoepner, I Kleiter Therapeutics and clinical risk management 12, 261, 2016 | 92 | 2016 |
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis R Hoepner, S Faissner, A Salmen, R Gold, A Chan Journal of central nervous system disease 6, JCNSD. S14049, 2014 | 81 | 2014 |
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study I Ayzenberg, J Schöllhammer, R Hoepner, K Hellwig, M Ringelstein, ... Journal of neurology 263 (3), 575-582, 2016 | 61 | 2016 |
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment S Faissner, R Hoepner, C Lukas, A Chan, R Gold, G Ellrichmann Therapeutic advances in neurological disorders 8 (5), 233-238, 2015 | 57 | 2015 |
Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab C Krogias, R Hoepner, A Müller, C Schneider-Gold, A Schröder, R Gold JAMA neurology 70 (8), 1056-1059, 2013 | 50 | 2013 |
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study A Miclea, VI Leussink, HP Hartung, R Gold, R Hoepner Journal of neurology 263 (8), 1626-1632, 2016 | 45 | 2016 |
Ictal autoscopic phenomena and near death experiences: a study of five patients with ictal autoscopies R Hoepner, K Labudda, TW May, M Schoendienst, FG Woermann, ... Journal of neurology 260 (3), 742-749, 2013 | 45 | 2013 |
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod R Hoepner, J Havla, C Eienbröker, B Tackenberg, K Hellwig, I Meinl, ... Multiple Sclerosis Journal 20 (13), 1714-1720, 2014 | 33 | 2014 |
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy R Hoepner, EM Kolb, S Dahlhaus, K Hellwig, O Adams, I Kleiter, ... Multiple sclerosis journal 23 (6), 830-835, 2017 | 32 | 2017 |
Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis R Hoepner, S Faissner, A Klasing, R Schneider, I Metz, B Bellenberg, ... Neurology-Neuroimmunology Neuroinflammation 2 (3), e85, 2015 | 31 | 2015 |
Informing patients about the impact of provocation methods increases the rate of psychogenic nonepileptic seizures during EEG recording R Hoepner, K Labudda, M Schoendienst, TW May, CG Bien, C Brandt Epilepsy & Behavior 28 (3), 457-459, 2013 | 31 | 2013 |
Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity A Miclea, M Miclea, M Pistor, A Hoepner, A Chan, R Hoepner Brain and behavior 7 (8), 2017 | 30 | 2017 |
Distinguishing between patients with pure psychogenic nonepileptic seizures and those with comorbid epilepsy by means of clinical data R Hoepner, K Labudda, TW May, M Schöndienst, CG Bien, C Brandt Epilepsy & Behavior 35, 54-58, 2014 | 26 | 2014 |
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod ME Evangelopoulos, A Miclea, L Schrewe, M Briner, A Salmen, ... CNS neuroscience & therapeutics, 2018 | 24 | 2018 |
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy R Hoepner, S Dahlhaus, S Kollar, B Zurawski, A Chan, I Kleiter, R Gold, ... Therapeutic advances in neurological disorders 7 (1), 3-6, 2014 | 14 | 2014 |
Unilateral autoscopic phenomena as a lateralizing sign in focal epilepsy R Hoepner, K Labudda, M Hoppe, M Schoendienst, R Schulz, ... Epilepsy & Behavior 23 (3), 360-363, 2012 | 12 | 2012 |
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases R Hoepner, S Faissner, G Ellrichmann, R Schneider, R Gold Therapeutic advances in neurological disorders 7 (6), 289-291, 2014 | 11 | 2014 |
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients R Hoepner, J Ahlbrecht, S Faissner, R Schneider, S Dahlhaus, O Adams, ... J Neurol Neurosurg Psychiatry 85 (10), 1177-1178, 2014 | 11 | 2014 |